Oxidative stress markers in bipolar disorder: A meta-analysis

Journal of Affective Disorders

Volumn 111, Issue 2-3, 2008, Pages 135-144

  Andreazza, Ana C ^a,b,c   Kauer Sant'Anna, Marcia ^a   Frey, Benicio N ^d   Bond, David J ^a   Kapczinski, Flavio ^b   Young, L Trevor ^a   Yatham, Lakshmi N ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Antioxidants enzymes; Bipolar disorder; Lipid peroxidation; Meta analysis; Nitric oxide; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE PEROXIDASE; NITRIC OXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

BIPOLAR DISORDER; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ANTIOXIDANTS; BIOLOGICAL MARKERS; BIPOLAR DISORDER; CONTROL GROUPS; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; NITRIC OXIDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 51349085199     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.04.013     Document Type: Review

References (63)

1. Abdalla D.S., Monteiro H.P., Oliveira J.A., and Bechara E.J. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin. Chem. 32 (1986) 805-807
2. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid. Redox Signal. 7 (2005) 1140-1149
3. Adam-Vizi V., and Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol. Sci. 27 (2006) 639-645
4. Aliyazicioglu R., Kural B., Colak M., Karahan S.C., Ayvaz S., and Deger O. Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. Tohoku J. Exp. Med. 213 (2007) 79-87
5. Andrades M., Ritter C., Moreira J.C., and Dal-Pizzol F. Oxidative parameters differences during non-lethal and lethal sepsis development. J. Surg. Res. 125 (2005) 68-72
6. Andreazza A.C., Cassini C., Rosa A.R., Leite M.C., de Almeida L.M., Nardin P., Cunha A.B., Cereser K.M., Santin A., Gottfried C., Salvador M., Kapczinski F., and Gonçalves C.A. Serum S100B and antioxidant enzymes in bipolar patients. J. Psychiatr. Res. 41 (2007) 523-529
7. Andreazza A.C., Frey B.N., Erdtmann B., Salvador M., Goncalves C.A., and Kapczinski F. DNA damage in bipolar disorder. Psychiatry Res. 153 (2007) 27-32
8. Bazan N.G., Marcheselli V.L., and Cole-Edwards K. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 1053 (2005) 137-147
9. Belmaker R.H. Medical progress: bipolar disorder. N. Engl. J. Med. 351 (2004) 476-486
10. Benes F.M., Matzilevich D., Burke R.E., and Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry 11 (2006) 241-251
11. Berk M., Dodd S., Kauer-Sant'anna M., Malhi G.S., Bourin M., Kapczinski F., and Norman T. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand., Suppl. 434 (2007) 41-49
12. Bonatto F., Polydoro M., Andrades M.E., da Frota Junior M.L., Dal-Pizzol F., Rotta L.N., Souza D.O., Perry M.L., and Moreira J.C. Effect of protein malnutrition on redox state of the hippocampus of rat. Brain Res. 1042 (2005) 17-22
13. Buttner N., Bhattacharyya S., Walsh J., and Benes F.M. DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr. Res. 93 (2007) 33-41
14. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 (1993) 689-695
15. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 7 (1986) 177-188
16. Droge W., and Schipper H.M. Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell. 6 (2007) 361-370
17. Egger M., Smith D.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
18. Engin A., Altan N., and Isik E. Erythrocyte glutathione levels in lithium-induced hypothyroidism. Drugs R.D. 6 (2005) 35-40
19. Frey B.N., Andreazza A.C., Kunz M., Gomes F.A., Quevedo J., Salvador M., Goncalves C.A., and Kapczinski F. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report. Prog. Neuro-psychopharmacol. Biol. Psychiatry 31 (2007) 283-285
20. Frye M.A., Watzl J., Banakar S., O'neill J., Mintz J., Davanzo P., Fischer J., Chirichigno J.W., Ventura J., Elman S., Tsuang J., Walot I., and Thomas M.A. Increased anterior cingulate/ medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. 32 (2007) 2490-2499
21. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 5789 (1980) 373-376 (Nov 27)
22. Garcia Y.J., Rodriguez-Malaver A.J., and Penaloza N. Lipid peroxidation measurement by thiobarbituric acid assay in rat cerebellar slices. J. Neurosci. Methods 144 (2005) 127-135
23. Gergerlioglu H.S., Savas H.A., Bulbul F., Selek S., Uz E., and Yumru M. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 697-702
24. Glasziou P.P., and Sanders S.L. Investigating causes of heterogeneity in systematic reviews. Stat. Med. 21 (2002) 1503-1511
25. Hedges L.V., and Olgin I. Statistical Methods for Meta-analysis (1995), Orlando Academic Press
26. Higuchi Y. Glutathione depletion-induced chromosomal DNA fragmentation associated with apoptosis and necrosis. Cell. Mol. Med. 8 (2004) 455-464
27. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14 (2005) 241-253
28. Kato T., and Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2 (2000) 180-190
29. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., and Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61 (2004) 300-308
30. Kroncke K.D., and Kolb-Bachofen V. Detection of nitric oxide interaction with zinc finger proteins. Methods Enzymol. 269 (1996) 279-284
31. Kuloglu M., Ustundag B., Atmaca M., Canatan H., Tezcan A.E., and Cinkilinc N. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell. Biochem. Funct. 20 (2002) 171-175
32. Kupfer D.J. The increasing medical burden in bipolar disorder. J. Am. Med. Assoc. 293 (2005) 2528-2530
33. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser Jr. V., da Silva Vargas R., Kapczinski F., Portela L.V., Souza D.O., Salvador M., and Gentil V. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci. Lett. 421 (2007) 33-36
34. Martinez-Aran A., Vieta E., Reinares M., Colom F., Torrent C., Sanchez-Moreno J., Benabarre A., Goikolea J.N., Comes M., and Salamero M. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry 161 (2004) 262-270
35. McIntyre R.S., Konarski J.Z., Soczynska J.K., Wilkins K., Panjwani G., Bouffard B., Bottas A., and Kennedy S.H. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr. Serv. 57 (2006) 1140-1144
36. Merikangas K.R., Ames M., Cui L., Stang P.E., Ustun T.B., Von Korff M., and Kessler R.C. The impact of comorbidity of mental and physical conditions on role disability in the US adult household population. Arch. Gen. Psychiatry 64 (2007) 1180-1188
37. Michael N., Erfurth A., Ohrmann P., Gossling M., Arolt V., Heindel W., and Pfleiderer B. Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex. Psychopharmacology 168 (2003) 344-346
38. Mirsa H.P., and Fridovich I. The role of superoxide anion in the antioxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 217 (1972) 3170-3175
39. Moro M.A., Almeida A., Bolanos J.P., and Lizasoain I. Mitochondrial respiratory chain and free radical generation in stroke. Free Radic. Biol. Med. 39 (2005) 1291-1304
40. Murad F. Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone?. Recent Prog. Horm. Res. 53 (1998) 43-59
41. Naydenov A.V., MacDonald M.L., Ongur D., and Konradi C. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch. Gen. Psychiatry 64 (2007) 555-564
42. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int. Clin. Psychopharmacol. 19 (2004) 89-95
43. Passos J.F., Saretzki G., Ahmed S., Nelson G., Richter T., Peters H., Wappler I., Birket M.J., Harold G., Schaeuble K., Birch-Machin M.A., Kirkwood T.B., and Von-Zglinicki T. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 5 (2007) 1138-1151
44. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., and Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 295 (2006) 676-680
45. Poon H.F., Calabrese V., Scapagnini G., and Butterfield D.A. Free radicals and brain aging. Clin. Geriatr. Med. 20 (2004) 329-359
46. Ranjekar P.K., Hinge A., Hegde M.V., Ghate M., Kale A., Sitasawad S., Wagh U.V., Debsikdar V.B., and Mahadik S.P. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res. 121 (2003) 109-122
47. Reznick A.Z., Cross C.E., Hu M.L., Suzuki Y.J., Khwaja S., Safadi A., Motchnik P.A., Packer L., and Halliwell B. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem. J. 286 (1992) 607-611
48. Robinson L.J., Thompson J.M., Gallagher P., Goswami U., Young A.H., Ferrier I.N., and Moore P.B. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J. Affect. Disord. 93 (2006) 105-115
49. Saretzki G., and Von-Zglinicki T. Replicative aging, telomeres, and oxidative stress. Ann. N. Y. Acad. Sci. 959 (2002) 24-29
50. Savas H.A., Gergerlioglu H.S., and Armutcu F. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J. Biol. Psychiatry 7 (2006) 51-55
51. Savas H.A., Gergerlioglu H.S., Gurel A., Selek S., Savas E., and Kocoglu E. Increased xanthine oxidase and malondialdehyde levels in euthymic bipolar patients. Klinik Psikiyatri Dergisi 8 (2005) 180-185
52. Savas H.A., Herken H., and Yurekli M. Possible role of nitric oxide and adrenomedullin in bipolar affective disorder. Neuropsychobiology 45 (2002) 57-61
53. Selek S., Savas H.A., Gergerlioglu H.S., Bulbul F., Uz E., and Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J. Affect. Disord. 107 1-3 (2008) 89-94
54. Shao L., Young L.T., and Wang J.F. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol. Psychiatry 58 (2005) 879-884
55. Sies H. Oxidative stress: from basic research to clinical application. Am. J. Med. 91 (1991) 31S-38S
56. Simon N.M., Smoller J.W., and McNamara K.L. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol. Psychiatry 60 (2006) 432-435
57. Stuehr D.J. Mammalian nitric oxide synthases. Biochim. Biophys. Acta. 1411 (1999) 217-230
58. Sun X., Wang J.F., Tseng M., and Young L.T. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J. Psychiatry Neurosci. 31 (2006) 189-196
59. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 497-500
60. Szabo C., Ischiropoulos H., and Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6 (2007) 662-680
61. Torres I.J., Boudreau V.G., and Yatham L.N. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta. Psychiatr. Scand. Suppl. 434 (2007) 17-26
62. Wills E.D. Mechanisms of lipid peroxide formation in animal tissues. Biochem. J. 99 (1996) 667-676
63. Yanik M., Vural H., Tutkun H., Zoroglu S.S., Savas H.A., Herken H., Koçyigit A., Keles H., and Akyol O. The role of the arginine-nitric oxide pathway in the pathogenesis of bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci. 254 (2004) 43-47